Analysis of Real-World PD-L1 Testing and PD-L1 IHC 28-8 and 22C3 Assay Concordance in Patients with Breast Cancer

被引：0
|
作者：
Prince, Emily [1 ]
Pratt, James [2 ]
Novotny, James [2 ]
Chizhevsky, Vladislav [3 ]
Ragheb, Josette William [3 ]
Huron, David [2 ]
机构：
[1] Bristol Myers Squibb, Philadelphia, PA USA
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] NeoGen Labs Inc, Aliso Viejo, CA USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
244
引用
收藏
页码：238 / 239
页数：2
相关论文
共 50 条
  • [11] Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays
    Chapel, David B.
    Stewart, Rachel
    Furtado, Larissa V.
    Husain, Aliya N.
    Krausz, Thomas
    Deftereos, Georgios
    HUMAN PATHOLOGY, 2019, 87 : 11 - 17
  • [12] PD-L1 assessment in oesophageal and gastro-oesophageal adenocarcinoma with PD-L1 IHC 22C3 pharmDx and PD-L1 IHC 28-8 pharmDx assays on Autostainer Link 48: The University Hospitals Birmingham experience over a period of 18 months
    O'Sullivan, B.
    Taniere, P.
    Charles, K.
    Pritchard, J.
    Gawthorpe, S.
    Thompson, J.
    Dowds, J.
    Diaz-Cano, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S868 - S868
  • [13] PD-L1 Detection and Assay Performance in Squamous Cell Carcinoma of the Head and Neck Using PD-L1 IHC 28-8 pharmDx
    Alvarez, S.
    Chan, J.
    William, J.
    Felten, C.
    Hanks, D. A.
    Northrup, A.
    Jaiswal, D.
    Jansson, M.
    Phillips, T.
    Segal, A.
    Satnick, I.
    McDonald, H.
    Little, H.
    Pierce, C.
    Wynne, B.
    Carnahan, J.
    Reddy, S. Y.
    Inzunza, H. D.
    Oroudjev, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [14] PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy
    Ahn, Soomin
    Kim, Kyoung-Mee
    MODERN PATHOLOGY, 2021, 34 (09) : 1719 - 1727
  • [15] PD-L1 IHC 22C3 pharmdx demonstrates precision and reproducibility in detecting PD-L1 expression in triple negative breast cancer.
    Kulangara, Karina
    Watts, Brittany
    Vilardo, Monika
    La Placa, Christopher
    Frederick, Judith
    Tabuena-Frolli, Siena
    Jansson, Malinka
    Kersch, Kristopher
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [16] Comparison Study of PD-L1 Immunohistochemistry Assays with 22C3 and 28-8: Analysis on Surgical Specimens of NSCLC
    Saito, T.
    Tsuta, K.
    Ishida, M.
    Ryota, H.
    Takeyasu, Y.
    Fukumoto, K.
    Matsui, H.
    Taniguchi, Y.
    Yanagimoto, H.
    Yokoi, T.
    Kurata, T.
    Murakawa, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1816 - S1817
  • [17] The Impact of Tumor Heterogeneity on PD-L1 Status, using PD-L1 IHC 22C3 pharmDx on Multiple Human Cancer Tissues
    Ruvalcaba-Rodarte, Jim
    Hund, Stephanie
    Moquin, Deanna
    Ponce, Francisco
    Adams, Micki
    Morones, Amber
    Borgert, Kiera
    Kersch, Kris
    Kulangara, Karina
    Kalpakoff, Megan
    LABORATORY INVESTIGATION, 2023, 103 (03) : S671 - S672
  • [18] Expression of PD-L1 clones (22C3 and 28-8) in hepatocellular carcinoma: a tertiary cancer care hospital experience
    Asghar, Kashif
    Bashir, Shaarif
    Hassan, Muhammad
    Farooq, Asim
    Abu Bakar, Muhammad
    Bilal, Sundus
    Hameed, Maryam
    Mehmood, Shafqat
    Loya, Asif
    EGYPTIAN LIVER JOURNAL, 2024, 14 (01)
  • [19] Expression of PD-L1 clones (22C3 and 28-8) in hepatocellular carcinoma: a tertiary cancer care hospital experience
    Kashif Asghar
    Shaarif Bashir
    Muhammad Hassan
    Asim Farooq
    Muhammad Abu Bakar
    Sundus Bilal
    Maryam Hameed
    Shafqat Mehmood
    Asif Loya
    Egyptian Liver Journal, 14
  • [20] Comparison Study of PD-L1 Immunohistochemistry Assays with 22C3 and 28-8: Analysis on 147 Surgically Resected NSCLC
    Saito, Tomohito
    Tsuta, Koji
    Takeyasu, Yuki
    Ryota, Hironori
    Fukumoto, Kento
    Matsui, Hiroshi
    Taniguchi, Yohei
    Yanagimoto, Hiroaki
    Yokoi, Takashi
    Kurata, Takayasu
    Murakawa, Tomohiro
    ANNALS OF ONCOLOGY, 2017, 28
12345